<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1664  Oxytetracycline and flunixin.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains 300  milligrams (mg) oxytetracycline base as amphoteric oxytetracycline and  20 mg flunixin base as flunixin meglumine.</p><p class="depth1"><em>(b)</em> Sponsor. See No. 055529 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Related tolerances. See Sec. Sec. 556.286 and 556.500 of this  chapter.</p><p class="depth1"><em>(d)</em> Conditions of use cattle--</p><p class="depth2"><em>(1)</em> Amount. Administer once as an  intramuscular or subcutaneous injection of 1 mL per 22 pounds (lb) body  weight (BW) (13.6 mg oxytetracycline and 0.9 mg flunixin per lb BW)  where retreatment of calves and yearlings for bacterial pneumonia is  impractical due to husbandry conditions, such as cattle on range, or  where their repeated restraint is inadvisable.</p><p class="depth2"><em>(2)</em> Indications for use. For the treatment of bacterial pneumonia  associated with Pasteurella spp. and for the control of associated  pyrexia in beef and nonlactating dairy cattle.</p><p class="depth2"><em>(3)</em> Limitations. Discontinue treatment at least 21 days prior to  slaughter of cattle. This drug product is not approved for use in female  dairy cattle 20 months of age or older, including dry dairy cows. Use in  these cattle may cause drug residues in milk and/or in calves born to  these cows. A withdrawal period has not been established in  preruminating calves. Do not use in calves to be processed for veal.  Federal law restricts this drug to use by or on the order of a licensed  veterinarian.  [76 FR 3489, Jan. 20, 2011, as amended at 79 FR 16192, Mar. 25, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
